Great Valley Advisor Group Inc. increased its position in Zoetis Inc. (NYSE:ZTS – Free Report) by 3.3% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 31,450 shares of the company’s stock after acquiring an additional 1,014 shares during the period. Great Valley Advisor Group Inc.’s holdings in Zoetis were worth $6,145,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also modified their holdings of the company. Leelyn Smith LLC lifted its position in Zoetis by 4.4% during the third quarter. Leelyn Smith LLC now owns 21,689 shares of the company’s stock worth $4,238,000 after buying an additional 909 shares during the period. Nwam LLC increased its stake in shares of Zoetis by 4.1% during the 3rd quarter. Nwam LLC now owns 4,908 shares of the company’s stock valued at $959,000 after acquiring an additional 193 shares during the last quarter. GM Advisory Group LLC lifted its holdings in shares of Zoetis by 35.7% during the 3rd quarter. GM Advisory Group LLC now owns 1,899 shares of the company’s stock worth $371,000 after acquiring an additional 500 shares during the period. Allen Capital Group LLC lifted its holdings in shares of Zoetis by 23.4% during the 3rd quarter. Allen Capital Group LLC now owns 2,466 shares of the company’s stock worth $482,000 after acquiring an additional 467 shares during the period. Finally, Biltmore Family Office LLC boosted its position in shares of Zoetis by 5.0% in the third quarter. Biltmore Family Office LLC now owns 1,771 shares of the company’s stock worth $346,000 after acquiring an additional 85 shares during the last quarter. Hedge funds and other institutional investors own 92.80% of the company’s stock.
Analyst Ratings Changes
Several analysts have recently issued reports on ZTS shares. Stifel Nicolaus boosted their price objective on shares of Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a research note on Wednesday, September 18th. Argus upgraded Zoetis to a “strong-buy” rating in a research note on Friday, August 9th. JPMorgan Chase & Co. lifted their price objective on Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. BTIG Research increased their target price on shares of Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a research report on Monday, August 12th. Finally, Piper Sandler lifted their price target on shares of Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a research report on Wednesday, August 14th. Ten research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $221.44.
Zoetis Stock Up 0.1 %
Shares of NYSE:ZTS opened at $176.96 on Friday. The company has a market capitalization of $79.84 billion, a price-to-earnings ratio of 33.26, a price-to-earnings-growth ratio of 2.71 and a beta of 0.90. The company has a 50 day moving average of $185.62 and a two-hundred day moving average of $180.61. Zoetis Inc. has a 52-week low of $144.80 and a 52-week high of $201.92. The company has a quick ratio of 2.27, a current ratio of 3.69 and a debt-to-equity ratio of 1.26.
Zoetis (NYSE:ZTS – Get Free Report) last released its quarterly earnings results on Monday, November 4th. The company reported $1.58 earnings per share for the quarter, beating analysts’ consensus estimates of $1.46 by $0.12. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. The business had revenue of $2.40 billion during the quarter, compared to analyst estimates of $2.29 billion. During the same period last year, the business earned $1.36 EPS. The business’s revenue was up 11.6% on a year-over-year basis. As a group, analysts forecast that Zoetis Inc. will post 5.9 earnings per share for the current fiscal year.
Zoetis Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 3rd. Investors of record on Thursday, October 31st will be paid a $0.432 dividend. This represents a $1.73 annualized dividend and a dividend yield of 0.98%. The ex-dividend date is Thursday, October 31st. Zoetis’s dividend payout ratio (DPR) is 32.52%.
About Zoetis
Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.
Featured Stories
- Five stocks we like better than Zoetis
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
- What is a Stock Market Index and How Do You Use Them?
- MarketBeat Week in Review – 11/18 – 11/22
- How to Use the MarketBeat Dividend Calculator
- 2 Finance Stocks With Competitive Advantages You Can’t Ignore
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS – Free Report).
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.